Research
Hormonal
While BAT activation does not cause weight loss, it may improve insulin sensitivity and glucose metabolism in humans.
If you have detectable brown fat, cold exposure might improve your insulin sensitivity and glucose metabolism, even if it doesn't help you lose weight.
GoodQualifiesHIGH confidence
BAT may play a role in improving insulin sensitivity in humans... these human studies have shown improved glucose uptake, whole body glucose disposal, and insulin sensitivity in activated BAT and cold-induced BAT.
Why this rating
Based on multiple human studies cited.
Source
Is activation of human brown adipose tissue a viable target for weight management?
Kara L. Marlatt et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2018
DOI 10.1152/ajpregu.00443.2017
narrative_reviewCited 35×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Activation of human brown adipose tissue (BAT) via cold exposure or pharmacological agents does not result in meaningful body weight loss and is not a viable strategy for obesity treatment.Good
- Pharmacological activation of brown adipose tissue using beta-3-adrenoreceptor agonists increases cardiovascular risk (heart rate and blood pressure) without providing weight loss benefits.Good
- BAT activation may play a role in weight loss maintenance by counteracting metabolic adaptation (slowed metabolism) after weight loss.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →